Thermo Fisher Scientific GENEART GmbH
Since entering the market in the year 2000 the company has become one of the worldwide leading specialists in gene synthesis and synthetic biology. GENEART provides the key technologies for the development and production of new medicines, services for the improvement of proteins (e.g. industrial enzymes, antibodies) or to construct cells for complex biological processes (e.g. bio-factories for the production or degradation of (bio-)polymers). The Regensburg location is now part of Thermo Fisher Scientific Inc, the world leader in serving science, with revenues of $17 billion and 50,000 employees in 50 countries.